Albert D Mason Inc Novartis Ag Transaction History

Albert D Mason Inc

$116 Million
Q2 2025

A detailed history of Albert D Mason Inc transactions in Novartis Ag stock. As of the latest transaction made, Albert D Mason Inc holds 24,364 shares of NVS stock, worth $3.17 Million. This represents 2.55% of its overall portfolio holdings.

Number of Shares

24,364

Previous 26,028 6.39%

Holding current value

$3.17 Million

Previous $2.9 Million 1.62%

% of portfolio

2.55%

Previous 2.37%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 29, 2025	SELL	$101.96 - $121.01 $169,661 - $201,360	-1,664 Reduced 6.39%	24,364 $2.95 Million
Q1 2025 Apr 16, 2025	BUY	$97.14 - $115.57 $1.24 Million - $1.48 Million	12,774 Added 96.38%	26,028 $2.9 Million
Q4 2024 Jan 15, 2025	SELL	$96.78 - $117.18 $21,581 - $26,131	-223 Reduced 1.65%	13,254 $1.29 Million
Q3 2024 Oct 22, 2024	SELL	$106.13 - $120.89 $7,853 - $8,945	-74 Reduced 0.55%	13,477 $1.55 Million
Q2 2024 Jul 16, 2024	BUY	$92.57 - $107.37 $5,831 - $6,764	63 Added 0.47%	13,551 $1.44 Million
Q1 2024 Apr 24, 2024	BUY	$95.27 - $108.47 $1,619 - $1,843	17 Added 0.13%	13,488 $1.31 Million
Q4 2023 Jan 03, 2024	SELL	$92.27 - $101.54 $2,768 - $3,046	-30 Reduced 0.22%	13,471 $1.36 Million
Q3 2023 Oct 10, 2023	SELL	$94.73 - $105.13 $140,200 - $155,592	-1,480 Reduced 9.88%	13,501 $1.38 Million
Q2 2023 Jul 25, 2023	SELL	$92.52 - $104.91 $40,431 - $45,845	-437 Reduced 2.83%	14,981 $1.51 Million
Q1 2023 Apr 11, 2023	SELL	$80.03 - $92.81 $5,121 - $5,939	-64 Reduced 0.41%	15,418 $1.42 Million
Q4 2022 Jan 11, 2023	SELL	$75.55 - $92.52 $1,737 - $2,127	-23 Reduced 0.15%	15,482 $1.41 Million
Q3 2022 Oct 12, 2022	BUY	$74.61 - $87.26 $6,714 - $7,853	90 Added 0.58%	15,505 $1.18 Million
Q2 2022 Jul 12, 2022	BUY	$80.52 - $93.75 $1,368 - $1,593	17 Added 0.11%	15,415 $1.3 Million
Q1 2022 Apr 20, 2022	SELL	$80.11 - $90.62 $23,552 - $26,642	-294 Reduced 1.87%	15,398 $1.35 Million
Q4 2021 Jan 25, 2022	BUY	$79.7 - $88.13 $198,771 - $219,796	2,494 Added 18.9%	15,692 $1.37 Million
Q3 2021 Oct 13, 2021	BUY	$81.78 - $95.14 $3,107 - $3,615	38 Added 0.29%	13,198 $1.08 Million
Q2 2021 Jul 14, 2021	SELL	$85.24 - $94.15 $36,653 - $40,484	-430 Reduced 3.16%	13,160 $1.2 Million
Q1 2021 Apr 14, 2021	SELL	$83.5 - $98.47 $11,272 - $13,293	-135 Reduced 0.98%	13,590 $1.16 Million
Q4 2020 Jan 12, 2021	BUY	$78.07 - $94.43 $11,398 - $13,786	146 Added 1.08%	13,725 $1.3 Million
Q3 2020 Oct 20, 2020	BUY	$82.14 - $91.0 $18,481 - $20,475	225 Added 1.68%	13,579 $1.18 Million
Q2 2020 Jul 21, 2020	SELL	$80.93 - $91.1 $5,665 - $6,377	-70 Reduced 0.52%	13,354 $1.17 Million
Q1 2020 Apr 15, 2020	BUY	$70.67 - $99.01 $3,180 - $4,455	45 Added 0.34%	13,424 $1.11 Million
Q4 2019 Jan 21, 2020	BUY	$84.35 - $95.37 $18,978 - $21,458	225 Added 1.71%	13,379 $1.27 Million
Q3 2019 Oct 23, 2019	BUY	$85.54 - $94.26 $3,849 - $4,241	45 Added 0.34%	13,154 $1.14 Million
Q2 2019 Jul 30, 2019	SELL	$75.4 - $92.8 $5,278 - $6,496	-70 Reduced 0.53%	13,109 $1.2 Million
Q1 2019 Apr 30, 2019	BUY	$75.32 - $86.15 $10,544 - $12,061	140 Added 1.07%	13,179 $1.27 Million
Q4 2018 Jan 29, 2019	SELL	$73.66 - $82.02 $5,524 - $6,151	-75 Reduced 0.57%	13,039 $1.12 Million
Q3 2018 Oct 30, 2018	BUY	$66.94 - $77.43 $168,354 - $194,736	2,515 Added 23.73%	13,114 $1.13 Million
Q2 2018 Jul 31, 2018	BUY	$64.91 - $73.36 $155,784 - $176,064	2,400 Added 29.27%	10,599 $801,000
Q1 2018 May 02, 2018	SELL	$70.39 - $84.15 $2,463 - $2,945	-35 Reduced 0.43%	8,199 $663,000
Q4 2017 Feb 06, 2018	BUY	$72.33 - $77.64 $1,808 - $1,941	25 Added 0.3%	8,234 $691,000
Q3 2017 Oct 18, 2017	BUY	$74.14 - $77.27 $608,615 - $634,309	8,209	8,209 $705,000

Others Institutions Holding NVS

# of Institutions

1,560

Shares Held

136M

Call Options Held

1.72M

Put Options Held

1.7M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $280B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Albert D Mason Inc, based on Form 13F filings with the SEC.

News

Stay updated on Albert D Mason Inc with notifications on news.

Account

Albert D Mason Inc Novartis Ag Transaction History